AGC Biologics vs BioReliance (Merck): CDMO Comparison

How does AGC Biologics compare to BioReliance (Merck)?

As of Oct 2026, AGC Biologics: 4 FDA inspections (including 1 NAI, 3 VAI and 0 OAI), 27 EMA/MHRA GMP certificates. Signal Score 79.9. BioReliance (Merck): 6 FDA inspections (including 2 NAI, 4 VAI and 0 OAI), 10 EMA/MHRA GMP certificates. Signal Score 80.3. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of AGC Biologics and BioReliance (Merck) on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score
80/100
Quality (FDA + GMP)
100/100
FDA inspections
4
— NAI / VAI / OAI
1 / 3 / 0
FDA warning letters
0
EMA GMP certificates (active)
27
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
2
Capacity
Available
Modalities
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Glasgow, UK · Rockville, MD
Signal Score
80/100
Quality (FDA + GMP)
97/100
FDA inspections
6
— NAI / VAI / OAI
2 / 4 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
10
Clinical programs (matched)
0
Capacity
—
Modalities
AAV, Lentiviral, Biologics

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • AGC Biologics holds 27 active EMA GMP certificates; BioReliance (Merck) does not appear in EudraGMDP.
  • BioReliance (Merck) maintains 10 MHRA / UK GMP certificates; AGC Biologics does not.

Across the cross-modality scorecard, BioReliance (Merck) carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: AGC Biologics vs BioReliance (Merck)

How does AGC Biologics compare to BioReliance (Merck)?

On CDMO Signal's composite Signal Score, AGC Biologics is 80/100 and BioReliance (Merck) is 80/100; AGC Biologics has 4 FDA inspections on record vs 6 for BioReliance (Merck); European coverage is 27 active EMA+MHRA certificates for AGC Biologics vs 10 for BioReliance (Merck). Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, AGC Biologics or BioReliance (Merck)?

Both AGC Biologics and BioReliance (Merck) maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. AGC Biologics has 4 FDA inspections on record; BioReliance (Merck) has 6.

How do AGC Biologics and BioReliance (Merck) compare on European GMP coverage?

AGC Biologics holds 27 active EMA GMP certificates and 0 MHRA / UK certificates. BioReliance (Merck) holds 0 active EMA GMP certificates and 10 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — AGC Biologics or BioReliance (Merck)?

AGC Biologics is matched to 2 ClinicalTrials.gov records as a manufacturing partner; BioReliance (Merck) is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

What does the Signal Score gap mean in practice?

AGC Biologics carries a Signal Score of 80/100 and BioReliance (Merck) carries 80/100 — essentially tied for BioReliance (Merck). The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating AGC Biologics and BioReliance (Merck) for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.